LUMITOUCH Trademark

Trademark Overview


On Friday, January 20, 2017, a trademark application was filed for LUMITOUCH with the United States Patent and Trademark Office. The USPTO has given the LUMITOUCH trademark a serial number of 87308530. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 26, 2024. This trademark is owned by Glaxo Group Limited. The LUMITOUCH trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances and auto injector devices filled with pharmaceutical preparations for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances and auto injector devices filled with pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; vaccines
lumitouch

General Information


Serial Number87308530
Word MarkLUMITOUCH
Filing DateFriday, January 20, 2017
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 26, 2024
Registration Number5305380
Registration DateTuesday, October 10, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 25, 2017

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances and auto injector devices filled with pharmaceutical preparations for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances and auto injector devices filled with pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 26, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Monday, January 30, 2017EXAMINERS AMENDMENT -WRITTEN
Tuesday, January 24, 2017NEW APPLICATION ENTERED
Thursday, January 26, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 30, 2017ASSIGNED TO EXAMINER
Monday, January 30, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, January 30, 2017EXAMINERS AMENDMENT E-MAILED
Wednesday, February 1, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 10, 2017ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Friday, June 16, 2017ELECTRONIC RECORD REVIEW COMPLETE
Wednesday, July 5, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 25, 2017PUBLISHED FOR OPPOSITION
Tuesday, July 25, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 10, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, December 4, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, January 30, 2017EXAMINER'S AMENDMENT ENTERED
Wednesday, December 4, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 10, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, November 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 8, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 8, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, November 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 26, 2024CANCELLED SEC. 8 (6-YR)